Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-192146 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 29, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
90,000
Total Value
$2,497,777.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 29, 2026 | Exercise/Conversion | 30,000 | $2.08 | $62,400.00 | 696,195 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 29, 2026 | Sale | 17,005 | $80.74 | $1,372,983.70 | 679,190 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 29, 2026 | Sale | 12,059 | $81.70 | $985,220.30 | 667,131 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 29, 2026 | Sale | 936 | $82.45 | $77,173.20 | 666,195 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 29, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 215,559 | Direct | โ | View Details |